Asian Pacific Journal of Cancer Prevention

  • 제15권10호
  • /
  • Pages.4193-4196
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Clinical Characteristics of Gynecologic Cancer Patients who Respond to Salvage Treatment with Lingzhi

  • 발행 : 2014.05.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Lingzhi or Ganoderma lucidum is a popular medicinal mushroom used as a health promotion herb in China and other Asian countries for thousands of years. There have many previous studies about the anti-cancer effects of lingzhi especially in vitro. The present study reports the clinical data of 5 gynecologic cancer patients who achieved stability in the disease after ingestion of lingzhi in the form of fruit body water extract and spores in a salvage setting. This report has been written to enhance the data describing the effect of lingzhi in cancer patients.

키워드

참고문헌

  1. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0 (2006), Available from: http://ctep.cancer.gov
  2. Eisenhauer EA, Therasse P, Bogaerts J, et al (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47. https://doi.org/10.1016/j.ejca.2008.10.026
  3. Gao YH, Dai XH, Chen GL,et al (2003). A randomized, placebo-controlled, multicenter study of Ganoderma lucidum (W.Curt.: Fr.) Lloyd (Aphyllophoromycetideae) polysaccharides $(Ganopoly^{(R)})$ in patients with advanced lung cancer. Int J Med Mushr, 5, 369-81
  4. Gao YH, Zhou SF, Jiang WQ,et al (2003). Effects of $Ganopoly^{(R)}$ (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest, 32, 201-15. https://doi.org/10.1081/IMM-120022979
  5. Jin X, Ruiz Beguerie J, Sze DM, Chan GF (2012). Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev, 6, CD007731.
  6. Joseph S, Sabulal B, George V, Antony KR, Janardhanan KK (2011). Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum. Acta Pharm, 61, 335-42.
  7. Li P, Deng YP, Wei XX, Xu JH (2013). Triterpenoids from Ganoderma lucidum and their cytotoxic activities. Nat Prod Res, 27, 17-22. https://doi.org/10.1080/14786419.2011.652961
  8. Martinez-Montemayor MM, Acevedo RR, Otero-Franqui E, Cubano LA, Dharmawardhane SF (2011). Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer. Nutr Cancer, 63, 1085-94. https://doi.org/10.1080/01635581.2011.601845
  9. Wu G, Qian Z, Guo J, et al (2012). Ganoderma lucidum extract induces G1 cell cycle arrest, and apoptosis in human breast cancer cells. Am J Chin Med, 63, 631-42.
  10. Wanmuang H, Leopairut J, Kositchaiwat C, Wananukul W, Bunyaratvej S (2007). Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. J Med Assoc Thai, 90, 179-81.
  11. Wanachiwanawin D, Piankijagum A, Chaiprasert A, et al (2006). Ganoderma lucidum: a cause of pseudoparasitosis. Southeast Asian J Trop Med Public Health, 37, 1099-102.
  12. Zhao, Ye G, Fu G, et al (2011). Ganoderma lucidum exerts antitumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin. Int J Oncol, 38, 1319-27.

피인용 문헌

  1. for Cancer Treatment vol.14, pp.3, 2015, https://doi.org/10.1177/1534735414568721
  2. Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivo vol.50, pp.5, 2017, https://doi.org/10.3892/ijo.2017.3939
  3. Ganoderma: A Cancer Immunotherapy Review vol.9, pp.1663-9812, 2018, https://doi.org/10.3389/fphar.2018.01217